Plaxone-TZ 1.125 Injection
Marketer
Shiron Pharmaceuticals
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Plaxone-TZ 1.125 Injection
Combiflox-TZ 1.125 Injection, a dual-action medication, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be strictly under a physician's guidance. Consistent adherence to the prescribed schedule is crucial; completing the entire course is vital, even with symptom improvement, as premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Seek emergency care for allergic reactions (e.g., rashes, pruritus, edema, dyspnea). Disclose all current medications to your doctor before commencing treatment. Pregnant or lactating individuals should consult their physician. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing to driving ability, refrain from operating vehicles if drowsiness or dizziness occurs. Adequate rest, nutritious food, and ample hydration contribute to faster recovery. Your doctor may order laboratory tests to monitor treatment response.
Uses of Plaxone-TZ 1.125 Injection
Infections caused by bacteria
Major Benefits of Plaxone-TZ 1.125 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Plaxone-TZ 1.125 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Plaxone-TZ 1.125 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Plaxone-TZ 1.125 Injection works:
Ceftriaxone and Tazobactum, the active components of Plaxone-TZ 1.125 Injection, work synergistically. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concomitant alcohol and Plaxone-TZ 1.125 Injection use.
PregnancySAFE IF PRESCRIBED
The injectable formulation Plaxone-TZ 1.125 is typically deemed safe for use during gestation. Preclinical trials using animals revealed minimal or no harmful consequences to the fetus; nevertheless, data from human clinical trials are scarce.
Breast feedingCAUTION
Administration of Plaxone-TZ 1.125 Injection necessitates careful consideration during lactation. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Plaxone-TZ 1.125 Injection can cause drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Plaxone-TZ 1.125 Injection use in patients suffering from renal impairment. Physician consultation is recommended.
LiverCAUTION
For patients with severe hepatic impairment, Plaxone-TZ 1.125 Injection requires careful administration and potential dose modification. Physician consultation is advised. Dosage alterations for Plaxone-TZ 1.125 Injection are generally unnecessary in individuals with mild or moderate liver dysfunction.
What if you forget to take Plaxone-TZ 1.125 Injection :
Should you forget a scheduled dose of Plaxone-TZ 1.125 Injection, seek advice from your physician.
Facts to Know About Plaxone-TZ 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently